Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma
NCT01283048
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Renal Cell Carcinoma
Interventions
DRUG:
BKM-120 Bevacizumab
Sponsor
Toni Choueiri, MD
Collaborators
[object Object]